As of 2026-04-02, 鸿翔中药科技有限责任公司's data on the DeepSeek platform in the 医药制造 category shows: The overall mention rate is 0.00%, below the industry average by 35.0 percentage points, with significant room for improvement. The first mention rate is only 0.00%, it is recommended to enhance first-position exposure in AI model responses. Negative mention rate (0.00%) has exceeded positive (0.00%), it is recommended to immediately initiate reputation repair. Among 6 competitors in the same category, 鸿翔中药科技有限责任公司's overall mention rate surpasses 0 brands. AIGeo recommends combining the above data to formulate targeted brand monitoring strategies to further enhance brand visibility and reputation in the AI search ecosystem.
鸿翔中药科技有限责任公司's Mention Rate is 0.00%, lower than 0.6% of competitors
鸿翔中药科技有限责任公司's First Mention is 0.00%, lower than 0.9% of competitors
鸿翔中药科技有限责任公司's Preferred Rate is 0.00%, lower than 100.0% of competitors
鸿翔中药科技有限责任公司's Positive Rate is 0.00%, lower than 8.9% of competitors
鸿翔中药科技有限责任公司's Negative Rate is 0.00%, higher than 96.3% of competitors
| Competitor | Mention Rate | First Mention | Preferred Rate | Positive Rate | Negative Rate | Actions |
|---|---|---|---|---|---|---|
| 恒恒瑞医药 | 71.43% | 20% | 38.1% | 65.71% | 5.71% | View Details |
| 中中国生物制药 | 42.86% | 0% | 0% | 34.29% | 0% | View Details |
| 云云南白药 | 24.29% | 0% | 0% | 14.29% | 1.43% | View Details |
| 济济川药业 | 1.43% | 0% | 0% | 1.43% | 0% | View Details |
| 北北京双鹭药业股份有限公司 | 0% | 0% | 0% | 0% | 0% | View Details |
| 华华北制药股份有限公司 | 0% | 0% | 0% | 0% | 0% | View Details |
| 鸿鸿翔中药科技有限责任公司 (Current Brand) | 0% | 0% | 0% | 0% | 0% | View Details |
